Urinary and rectal incontinence during gabapentin therapy

Journal of Supportive Oncology

Volumn 6, Issue 4, 2008, Pages 152-

  Iyer, Renuka ^a   Egloff, Lori ^a   Frass, Jamie ^a   Harris, Juan Diego ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; MORPHINE SULFATE; PAROXETINE;

AGED; ARTICLE; CASE REPORT; DOSE RESPONSE; DRUG WITHDRAWAL; FECES INCONTINENCE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; METASTASIS; NEUROPATHIC PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; URINE INCONTINENCE;

AGED; AMINES; ANTICONVULSANTS; CARCINOMA, NON-SMALL-CELL LUNG; CYCLOHEXANECARBOXYLIC ACIDS; FECAL INCONTINENCE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; LUNG NEOPLASMS; PAIN; URINARY INCONTINENCE;

EID: 42549116639     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Gil-Nagel A, Gapany S, Blesi K, Villanueva N, Bergen D. Incontinence during treatment with gabapentin Neurology 1997;48:1467-1468.
2. Handforth A, Treiman DM, Efficacy and tolerance of long-term, high-dose gabapentin:additional observations. Epilepsia 1994;35:1032-1037.
3. Cheng JK, Chiou LC. Mechanisms of the antinociceptive action of gabapentin. J. Pharmacol Sci 2006;100:471-486.
4. Stanfa LC, Singh L, Williams RG, Dickenson AH. Gabapentin, ineffective in normal rat, markedly reduces C-fibre evoked responses after inflammation. Neuroreport 1997;8:587-590.
5. Yoshimura N, Chancellor MB. Current and future pharmacological treatment for overactive bladder. J Urol 2002;168:1897-1913.
6. Kim YT, Kwon DD, Kim J, Kim DK, Lee JY, Chancellor MB. Gabapentin for overactive bladder and nocturia after anticholinergic failure. Int Braz J Urol 2004;30:275-278.